Insider purchase at Radius Health (RDUS) prolongs buy activity of Last 90 Days

Wednesday, September 13, 2017 10:15 PM ET

Insider purchase at Radius Health (RDUS) prolongs buy activity of Last 90 Days

One Radius Health insider — Biotech Growth N V, 10% Owner — today, bought 50,000 shares having a market value of approximately $1,770,820, as disclosed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 260,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 310,000 shares and have averaged 155,000 shares per transaction over this time period.

The level of buy/sell trading at Radius Health is is higher than the 266 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 298 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for Radius Health insiders was also higher. Within the peer group there were 7,621,758 shares purchased and 14,304,013 shares sold with company insiders having sold 22,424 shares on average.

Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in composing and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.